烧伤合并毛霉病:综述
本文系统回顾1946年至今的文献,共纳入151例烧伤合并毛霉病病例。病死率为54.5%,躯干中轴部位受累者病死率较孤立外周部位受累者显著升高。标准治疗为及时彻底清创,术中冰冻切片有助于临床决策;全身治疗均未达统计学显著,但两性霉素B呈趋向显著。
要点
- 烧伤创面出现散在黑/坏死性溃疡、白色真菌成分且清创后仍进展时应警惕毛霉病。
- 诊断依靠创面组织学检查,但常被延迟。
- 推荐早期彻底清创,并联合欧洲医学真菌学联盟指南的静脉脂质体/脂质复合物两性霉素B方案。
核心结论
- 烧伤合并毛霉病罕见且病死率高,标准治疗为及时彻底清创;作者推荐早期彻底清创并联合欧洲医学真菌学联盟指南的全身抗真菌方案。
研究设计与样本
- 本文为文献综述,检索1946年至今的出版物,共纳入151例烧伤合并毛霉病病例。
主要发现
- 151例烧伤合并毛霉病患者病死率为54.5%。
- 与孤立外周部位受累相比,躯干中轴部位受累时病死率显著升高。
- 术中冰冻切片辅助清创有助于临床决策。
- 没有任何全身治疗达到统计学显著,但两性霉素B呈趋向显著。
- 局部两性霉素B或高压氧虽无强证据,但在部分病例中可能获益。
关键数值与推荐
- 欧洲医学真菌学联盟指南推荐静脉脂质体/脂质复合物两性霉素B剂量大于5mg/kg/日。
- 泊沙康唑800mg/日分次给药,用作挽救治疗或口服降阶梯治疗。
临床怎么用
- 作者推荐早期彻底清创,并联合欧洲医学真菌学联盟指南的静脉脂质体/脂质复合物两性霉素B大于5mg/kg/日方案。
- 泊沙康唑800mg/日分次给药可作为挽救治疗或口服降阶梯治疗。
- 作者认为局部两性霉素B或高压氧在部分病例中可能获益,但无强证据。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Mucormycosis is a rare fungal infection with a high mortality rate. It presents with scattered black/necrotic ulcers, white fungal elements, and progression of wounds despite seemingly adequate debridement. Diagnosis is confirmed on wound histology; however, this is often delayed. There is currently no comprehensive review of burn-related mucormycosis within the literature, making this the first article to provide evidence-based treatment guidance. We performed a review of publications from 1946 to the present. There were 151 cases of mucormycosis complicating burns. The mortality rate was 54.5%, and there was a significant increase in mortality with axial body site involvement compared with isolated peripheral involvement. The standard treatment was prompt and radical debridement. Utilization of frozen section to guide debridement aided in clinical decision making. No systemic treatment reached statistical significance; however, amphotericin B trended toward significance. Although there is no strong evidence for topical amphotericin B or hyperbaric oxygen, there may be benefit in some cases. This study recommends early radical debridement in conjunction with the European Confederation of Medical Mycology guidelines of IV liposomal/lipid complex amphotericin B more than 5mg/kg/day, with posaconazole 800 mg daily in divided doses as a salvage or oral step-down.
引用
- Littlehales E, Teague R, Andrew D, et al. Mucormycosis in Burns: A Review. J Burn Care Res. 2022. PMID: 34874443. doi:10.1093/jbcr/irab236
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。